Editorial: Toxicity Mechanism and Clinical Features of PD-1/PD-L1 Inhibitors in Treatment of Cancer, Volume I

Saved in:

Bibliographic Details
Main Authors:	Xiangyi Kong (Author), Ryan J Sullivan (Author), Caisheng Wu (Author), Lin Zhang (Author), Yu Jiang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

MARC


LEADER	00000 am a22000003u 4500
001	doaj_12b61b01e6bd4430b81f5b0a9ed2d4f6
042			\|a dc
100	1	0	\|a Xiangyi Kong \|e author
700	1	0	\|a Ryan J Sullivan \|e author
700	1	0	\|a Caisheng Wu \|e author
700	1	0	\|a Lin Zhang \|e author
700	1	0	\|a Lin Zhang \|e author
700	1	0	\|a Lin Zhang \|e author
700	1	0	\|a Yu Jiang \|e author
245	0	0	\|a Editorial: Toxicity Mechanism and Clinical Features of PD-1/PD-L1 Inhibitors in Treatment of Cancer, Volume I
260			\|b Frontiers Media S.A., \|c 2022-05-01T00:00:00Z.
500			\|a 1663-9812
500			\|a 10.3389/fphar.2022.898368
546			\|a EN
690			\|a PD-1/PD-L1 inhibitors
690			\|a toxicity mechanism
690			\|a clinical features
690			\|a immunotherapy
690			\|a cancer
690			\|a Therapeutics. Pharmacology
690			\|a RM1-950
655	7		\|a article \|2 local
786	0		\|n Frontiers in Pharmacology, Vol 13 (2022)
787	0		\|n https://www.frontiersin.org/articles/10.3389/fphar.2022.898368/full
787	0		\|n https://doaj.org/toc/1663-9812
856	4	1	\|u https://doaj.org/article/12b61b01e6bd4430b81f5b0a9ed2d4f6 \|z Connect to this object online.